Navigation Links
Savient Pharmaceuticals Reports First Quarter 2013 Financial Results
Date:5/15/2013

BRIDGEWATER, N.J., May 15, 2013 /PRNewswire/ -- Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) today reported financial results for the three months ended March 31, 2013.  Net sales of KRYSTEXXA® (pegloticase) were $4.4 million for the first quarter of 2013, a 6% decrease from the fourth quarter of 2012 and a 43% increase over the first quarter of 2012.  For the three-month period ended March 31, 2013, the Company had a net loss of $24.4 million or $0.34 per share, on total revenues of $4.7 million, compared with a net loss of $34.2 million or $0.49 per share, on total revenues of $3.5 million during the same period in 2012.  Savient ended the quarter with approximately $68.8 million in cash and short-term investments as compared to $96.3 million in cash and short-term investments as of the prior quarter.

Financial Results of Operations for the Three Months Ended March 31, 2013Net revenues of the Company increased $1.2 million, or 33%, to $4.7 million for the three-month period ended March 31, 2013, from $3.5 million for the three-month period ended March 31, 2012, primarily driven by the impact of our price increases on KRYSTEXXA. Since the beginning of 2012, we have increased the selling price of KRYSTEXXA by 67% to $3,850 per vial, effective January 16, 2013.

Cost of goods sold increased $1.9 million, or 106%, to $3.6 million for the three-month period ended March 31, 2013, from $1.7 million for the three-month period ended March 31, 2012. The increase is primarily due to a $2.1 million charge to reserve for KRYSTEXXA finished goods and raw material inventory.

Research and development expenses decreased $1.1 million, or 15%, to $6.1 million for the three-month period ended March 31, 2013, from $7.2 million for the three-month period ended March 31, 2012. The decrease is primarily due t
'/>"/>

SOURCE Savient Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
2. Savient Pharmaceuticals to Present at the Bank of America Merrill Lynch 2012 Health Care Conference
3. Savient Pharmaceuticals Announces CEO Appointment and Reorganization Plan to Drive Long-Term Growth
4. Savient Pharmaceuticals to Hold Second Quarter 2012 Financial Results Conference Call on Wednesday, August 8, 2012
5. Savient Pharmaceuticals Receives Favorable Decision In Tang Capital Litigation
6. Savient Pharmaceuticals Adopts Stockholder Rights Plan
7. Savient Pharmaceuticals to Present at the Canaccord Genuity 32nd Annual Growth Conference
8. Savient Pharmaceuticals to Present at the Rodman & Renshaw 14th Annual Healthcare Conference
9. Savient Pharmaceuticals to Present at the 6th Annual Imperial Capital Global Opportunities Conference
10. Savient Pharmaceuticals Reports Third Quarter 2012 Financial Results
11. Savient Announces the Election of Robert G. Savage to its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... -- Unilife Corporation (NASDAQ: UNIS, ASX: UNS), a designer, manufacturer ... that its Chairman and CEO, Alan Shortall , ... Annual Healthcare Conference at the New York Palace Hotel ... The conference presentation will be broadcast ... To listen, please go to: http://ir.unilife.com/events.cfm . An ...
(Date:11/26/2014)... Calif. and LONDON , Nov. ... and AstraZeneca (NYSE: AZN ) today announced that ... two doses of brodalumab in more than 1,800 patients with ... both Stelara ® (ustekinumab) and placebo at week 12. ... weight-based analysis group were each shown to be superior to ...
(Date:11/26/2014)... -- Halozyme Therapeutics, Inc. (NASDAQ: HALO ) will ... New York on Wednesday, December 3, 2014 ... Helen Torley , President and Chief Executive Officer, will provide ... through the "Investors" section of Halozyme,s corporate website at ... 90 days following the event. To access the live webcast, ...
Breaking Medicine Technology:Unilife to Present at the Piper Jaffray 26th Annual Healthcare Conference on December 2nd 2Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 2Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 3Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 4Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 5Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 6Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 7Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 8Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 9Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 10Halozyme Therapeutics To Present At The Piper Jaffray Healthcare Conference 2
... MINNEAPOLIS, Sept. 29 ProUroCare Medical Inc. (OTC Bulletin ... imaging products, today announced the signing of an agreement ... LP of Juno Beach, Fla.  The proceeds of the ... portfolio and to support scale-up activities associated with final ...
... PROSPECT, Ill., Sept. 29 Earlier this year, the National ... was introduced to the AWARxE campaign, which was created and ... the power of the campaign, NABP obtained the AWARxE program ... level. The Foundation was inspired to create ...
Cached Medicine Technology:UPDATE - ProUroCare Announces $3 Million Financing Agreement 2UPDATE - ProUroCare Announces $3 Million Financing Agreement 3NABP Purchases AWARxE Consumer Protection Program 2
(Date:11/27/2014)... At The Little Gym, we know that being ... surprise when a recent study confirmed that regular physical ... Journal of Pediatrics found that “Promoting physical activity ... school years may be important not only for health, ... two groups of children; those that were engaging in ...
(Date:11/27/2014)... 27, 2014 Ethane Web Technologies, which ... announced online reputation management service. , The company ... about the world of internet marketing and algorithms of ... , Ethane Web Technologies does not work with the ... the project to reach a conclusion what will work ...
(Date:11/27/2014)... November 27, 2014 VeloReality Inc. ... new Real Life Videos (RLVs) of world-famous velo courses for ... as well as other popular indoor velo trainers. Two dozen ... worldwide before the end of November -- in time ... total number of rides in the VeloReality collection to over ...
(Date:11/27/2014)... (PRWEB) November 27, 2014 Serious Buyer, ... for vintage 1969 Jimi Hendrix Tuscaloosa Memorial Coliseum concert posters. ... bands played at the University of Alabama. Jimi Hendrix ... to Hawley, “It started with Gary Weinberger who was ... at University Programs Council. The council was responsible for ...
(Date:11/26/2014)... Angeles, CA (PRWEB) November 26, 2014 ... to treat themselves this holiday season! With Parsa Mohebi ... incredible 10% off of their next FUE procedure, making ... transplant. , FUE—which stands for “Follicular Unit Extraction”—is an ... advantages over traditional “strip” Follicular Unit Transplantation (FUT). FUE, ...
Breaking Medicine News(10 mins):Health News:Ethane Web Technologies Announces Online Reputation Management Service 2Health News:Winter 2015 Weather Forecast Is Warm and Dry For VeloReality Riders With New RLV Offering 2Health News:Winter 2015 Weather Forecast Is Warm and Dry For VeloReality Riders With New RLV Offering 3Health News:Serious Buyer Announces His Search For Vintage 1969 Jimi Hendrix Tuscaloosa Memorial Coliseum Concert Posters 2Health News:FUE Special at Parsa Mohebi Hair Restoration This Holiday Season 2
... , SILVER SPRING, Md., Aug. 21 ... from People for the Ethical Treatment of Animals (PETA) promoting vegetarianism ... billboard ad displays an image of an overweight woman in a ... Blubber: Go Vegetarian ." This ad is an unmistakable example of ...
... , , ATLANTA, Aug. 21 ... ceremony is to take place August 27, 2009 in Milledgeville, GA. ... Fund Commission announces its annual meeting will take place on Thursday, ... Military College - Legislative Chamber/Old Capitol Building in Milledgeville, GA. The ...
... , , LOS ANGELES, Aug. 21 ... of 2009 (Recovery Act) grants totaling $19.4 million from the National ... date was $1.9 million, awarded to UCLA,s Laboratory of Neuro Imaging ... the brain is structured and how it works. , ...
... CHICAGO, Aug. 21 Illinois U.S. Senate candidate Cheryle Jackson today ... the dual goals of containing costs and expanding access to quality ... Jackson said that health care cooperatives are not a ... public plan that competes with the private insurance industry because cooperatives ...
... , ... Help Plans Attract, Retain and Serve Health Insurance Consumers , ... Orlando, FL (Vocus) August 21, 2009 ... health coverage. This is making individual consumers become more involved in the health insurance ...
... Los Angeles, London, New Delhi, Singapore and Washington DC (August ... tumours could benefit from a lighter touch but from ... have created a touchy-feely robot that detects tougher tumour tissue ... a human. The technique also minimises tissue damage. Surgeons ...
Cached Medicine News:Health News:The Obesity Society Calls Billboard Campaign Offensive and Off-Target 2Health News:Brain and Spinal Injury Trust Fund Commission Annual Meeting and Award Ceremony 2Health News:UCLA Awarded More Than $19 Million In NIH Stimulus Funds 2Health News:U.S. Senate Candidate Cheryle Jackson: 'Public Option Critical to Real Health Care Reform' 2Health News:Connextions Cited in Leading Industry Analyst Firm's 'Hype Cycle for Healthcare Payers' 2Health News:Connextions Cited in Leading Industry Analyst Firm's 'Hype Cycle for Healthcare Payers' 3Health News:Connextions Cited in Leading Industry Analyst Firm's 'Hype Cycle for Healthcare Payers' 4Health News:Robot's gentle touch aids delicate cancer surgery 2Health News:Robot's gentle touch aids delicate cancer surgery 3
The CIC Pro Clinical Information Center brings together vital patient information from multiple monitoring devices....
... Alaris System integrates drug infusion,with patient ... a single, modular platform. With multiple ... modules as you,need them, keeping the ... a minimum while managing the unique ...
... Gemini Family of infusion pumps ... a collective series of administration ... line offers a wide variety ... sets, each featuring the patented ...
... These specialty Eraser instruments have ... surgeon with the right tool for ... introduced a series of 25 gauge ... provide discrete treatment of target tissues ...
Medicine Products: